https://www.prnewswire.com/news-releases/micurx-initiates-us-phase-2-clinical-trial-for-novel-antibiotic-mrx-i-300041065.html
/PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that it has...
u sclinical trialinitiatesphasenovel
https://pubmed.ncbi.nlm.nih.gov/16355681/
A phase I clinical trial evaluating the toxicity of orally-administered imatinib mesylate was performed in 9 tumor-bearing cats. Imatinib is a small molecule,...
phase iclinical trialimatinib mesylategleevec
https://nurabio.com/news/nura-bio-initiates-phase-1-clinical-trial-for-its-oral-brain-penetrant-sarm1-inhibitor-nb-4746/
Nura Bio, Inc. (Nura Bio), a biopharmaceutical company developing neuroprotective, small molecule therapies for the treatment of debilitating neurological...
phase iclinical trialnurabioinitiates
https://www.prnewswire.com/ae/news-releases/yishengbio-announces-pika-recombinant-covid-19-vaccine-received-phase-i-clinical-trial-ind-clearance-from-the-uae-301336132.html
/PRNewswire/ -- YishengBio Co., Ltd ("YishengBio") today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase...
phase iannouncespikarecombinantcovid
https://www.news-medical.net/news/20161007/Researchers-report-high-response-rate-with-single-drug-in-phase-III-trial-of-paediatric-brain-cancer.aspx
A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and...
response ratein phaseresearchersreporthigh
https://www.biospace.com/gt-biopharma-announces-completion-of-dosing-in-phase-1-clinical-trial-of-gtp-004-for-myasthenia-gravis
The results provide evidence that GTP-004 enables the safe and well-tolerated administration of doses of pyridostigmine.
in phasegtannouncescompletiondosing
https://www.prnewswire.com/news-releases/blueberry-therapeutics-limited-announce-positive-results-from-a-phase-i-ii-clinical-trial-847837328.html
/PRNewswire/ -- Blueberry Therapeutics Limited ("Blueberry Therapeutics"), a modern drug discovery and development company committed to the development of...
phase iblueberrytherapeuticslimitedannounce